Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel
出版年份 2013 全文链接
标题
Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel
作者
关键词
-
出版物
BJU INTERNATIONAL
Volume 114, Issue 6b, Pages E11-E17
出版商
Wiley
发表日期
2013-10-29
DOI
10.1111/bju.12531
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Prognostic Role of the Preoperative Absolute Lymphocyte Count and Absolute Monocyte Count in Patients With Resected Advanced Melanoma
- (2015) Nicole M. Rochet et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
- (2013) M Santoni et al. BRITISH JOURNAL OF CANCER
- Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review
- (2013) D.A. Loblaw et al. CLINICAL ONCOLOGY
- Preoperative Neutrophil/Lymphocyte Ratio Predicts Overall Survival and Extravesical Disease in Patients Undergoing Radical Cystectomy
- (2013) L. Spencer Krane et al. JOURNAL OF ENDOUROLOGY
- Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma
- (2013) Michela de Martino et al. JOURNAL OF UROLOGY
- The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer
- (2012) Jatinder Goyal et al. BJU INTERNATIONAL
- A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
- (2012) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Neutropenia as a Potential Pharmacodynamic Marker for Docetaxel-Based Chemotherapy in Men With Metastatic Castration-Resistant Prostate Cancer
- (2012) Gregory R. Pond et al. Clinical Genitourinary Cancer
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
- (2011) Basem Azab et al. ANNALS OF SURGICAL ONCOLOGY
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- The Role of Abiraterone Acetate in the Management of Prostate Cancer: A Critical Analysis of the Literature
- (2011) Guru Sonpavde et al. EUROPEAN UROLOGY
- New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety
- (2011) Himisha Beltran et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2011) Nicolas Mottet et al. EUROPEAN UROLOGY
- Current Vaccination Strategies for Prostate Cancer
- (2011) Steven Joniau et al. EUROPEAN UROLOGY
- Expanding Treatment Options for Metastatic Prostate Cancer
- (2011) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study
- (2011) K Shafique et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer
- (2011) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prognostic Impact of C-reactive Protein for Determining Overall Survival of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel
- (2011) Masaya Ito et al. UROLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection
- (2010) Farhan Rashid et al. World Journal of Surgical Oncology
- Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
- (2009) A. J. Armstrong et al. CLINICAL CANCER RESEARCH
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
- (2008) Khaled M. Sarraf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now